JEPQ pulled back 3.5% this week to close at $59.32, a modest dip for a covered-call income ETF that has otherwise outperformed pure Nasdaq beta through the first half of 2026 — and the most interesting story this week isn't the price move, it's a quiet but sharp rise in the cost to borrow shares that few income-fund watchers would expect.
The borrow cost has nearly tripled over the past month, rising 191% to reach 1.25% annualised. That number is still modest in absolute terms, but the pace of the move is notable for a $40 billion ETF that has historically traded with near-zero friction in the lending market. The week-on-week picture actually shows a slight easing — CTB fell from a two-day spike near 2.3% on July 6 back to 1.25% by July 7 — suggesting the demand that briefly tightened borrows has partially unwound. Availability remains genuinely comfortable at roughly 219% of short interest, meaning there are more than two shares available to lend for every share currently borrowed, well above the year's floor of 131%. That looseness caps any squeeze narrative before it starts.
Short interest itself barely registers as a concern. At under 0.04% of the float — and down nearly 79% on the week and 87% over the past month — there is almost no directional short positioning in JEPQ worth discussing. The mid-June spike to roughly 11 million shares short collapsed as suddenly as it appeared, suggesting it was likely a hedging artefact or creation-redemption flow rather than a conviction short. The ORTEX short score of 39 reflects this: broadly neutral, edging slightly lower from 45 a fortnight ago.
Options positioning is the calmest signal in the stack. The put/call ratio of 0.46 is essentially flat against its 20-day average of 0.46, with a z-score barely above zero. That means options traders are neither rushing for downside protection nor aggressively buying calls — consistent with how income-oriented holders typically behave. They own JEPQ for the monthly distribution, not directional exposure. The 52-week range for the PCR runs from 0.34 to 1.58, and the current reading sits near the calm, call-heavy end of that range.
The income story remains intact. Monthly distributions have been rising — $0.51 in March, $0.56 in May, and $0.64 in June — reflecting both premium income from the options overlay and underlying Nasdaq dividend flows. With the fund down 3.5% on the week but still up roughly 0.7% on the month, the total-return picture including distributions looks considerably more supportive than the price alone suggests. That trade-off — capped upside during rallies, cushioned drawdowns with income — is exactly what the strategy promises, and the June recovery followed by this week's tech-sector softness is a textbook illustration of how it behaves.
What to watch next is whether the borrow-cost spike that briefly appeared on July 6 reflects a new pattern of periodic demand for short exposure in covered-call ETFs, or whether it fades entirely as the mid-June hedging flows fully unwind.
See the live data behind this article on ORTEX.
Open JEPQ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
